Jefferies Financial Group Inc. Buys 20,300 Shares of Ryan Specialty Holdings Inc. $RYAN

Jefferies Financial Group Inc. purchased a new stake in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 20,300 shares of the company’s stock, valued at approximately $751,000.

Other large investors have also added to or reduced their stakes in the company. Vulcan Value Partners LLC boosted its holdings in shares of Ryan Specialty by 20.0% in the 2nd quarter. Vulcan Value Partners LLC now owns 7,912,669 shares of the company’s stock worth $298,782,000 after purchasing an additional 1,317,334 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Ryan Specialty by 1,374.2% during the 1st quarter. Renaissance Technologies LLC now owns 536,600 shares of the company’s stock valued at $18,105,000 after purchasing an additional 500,200 shares during the last quarter. Bank of America Corp DE raised its holdings in shares of Ryan Specialty by 34.8% during the 1st quarter. Bank of America Corp DE now owns 1,508,083 shares of the company’s stock valued at $50,883,000 after buying an additional 389,505 shares in the last quarter. Clarkston Capital Partners LLC purchased a new position in shares of Ryan Specialty during the 1st quarter valued at about $10,187,000. Finally, Confluence Investment Management LLC purchased a new position in shares of Ryan Specialty during the 2nd quarter valued at about $7,137,000. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Ryan Specialty Trading Up 1.4%

Shares of RYAN traded up $0.65 during trading hours on Friday, hitting $46.80. The company had a trading volume of 3,119,407 shares, compared to its average volume of 2,198,085. Ryan Specialty Holdings Inc. has a 52-week low of $29.28 and a 52-week high of $58.91. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 4.03. The stock’s 50 day moving average price is $41.17 and its 200 day moving average price is $39.00. The firm has a market cap of $11.77 billion, a P/E ratio of 57.78, a P/E/G ratio of 0.97 and a beta of 0.54.

Ryan Specialty (NYSE:RYAN – Get Free Report) last issued its earnings results on Thursday, October 29th. The company reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.02. Ryan Specialty had a return on equity of 47.77% and a net margin of 8.25%. The company had revenue of $789.96 million during the quarter, compared to analysts’ expectations of $792.99 million. During the same period in the prior year, the business posted $0.47 EPS. On average, research analysts predict that Ryan Specialty Holdings Inc. will post 2.18 EPS for the current year.

Ryan Specialty Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 24th. Shareholders of record on Tuesday, November 10th will be given a $0.13 dividend. The ex-dividend date is Tuesday, November 10th. This represents a $0.52 annualized dividend and a yield of 1.1%. Ryan Specialty’s payout ratio is presently 64.20%.

Insiders Place Their Bets

In other news, CEO Benjamin Wuller sold 50,000 shares of the stock in a transaction that occurred on Monday, November 9th. The stock was sold at an average price of $47.31, for a total transaction of $2,365,500.00. Following the completion of the sale, the chief executive officer owned 94,095 shares of the company’s stock, valued at approximately $4,451,634.45. This represents a 34.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 52.03% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on RYAN shares. UBS Group cut their target price on Ryan Specialty from $55.00 to $52.00 and set a “buy” rating for the company in a research note on Monday, November 2nd. Cantor Fitzgerald increased their price target on shares of Ryan Specialty from $34.00 to $41.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. lifted their price target on shares of Ryan Specialty from $39.00 to $45.00 and gave the stock an “underweight” rating in a research note on Monday, August 3rd. Citigroup boosted their price objective on shares of Ryan Specialty from $50.00 to $53.50 and gave the stock a “buy” rating in a report on Monday, August 3rd. Finally, Barclays boosted their price objective on shares of Ryan Specialty from $46.00 to $48.00 and gave the stock an “overweight” rating in a report on Friday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $52.62.

Get Our Latest Analysis on RYAN

Ryan Specialty Profile

(Free Report)

Ryan Specialty is a specialty insurance organization that provides distribution, underwriting and related services to insurance brokers, agents and carriers. Its business includes wholesale brokerage, which helps insurance professionals place coverage for risks that may be difficult to insure in the standard market, and underwriting management services for specialty insurance products. The company works across a range of property and casualty insurance lines, including professional liability, transportation, property, casualty and other specialty risks.

Further Reading

Want to see what other hedge funds are holding RYAN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report).

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.